The global automated and closed cell therapy processing systems market is witnessing rapid expansion as the commercialization of advanced cell therapies accelerates worldwide. Rising demand for standardized, contamination-controlled, and scalable manufacturing platforms is driving adoption of automated and closed processing systems across research institutions, biotechnology companies, and cell therapy manufacturing facilities.

According to Straits Research analysis, the global automated and closed cell therapy processing systems market size is valued at USD 1.64 billion in 2025 and is estimated to reach USD 7.61 billion by 2034, growing at a CAGR of 18.62% during the forecast period.

Base Year: 2025
Forecast Period: 2025–2034

Unlock Full Report Insights and Strategic Analysis- https://straitsresearch.com/report/automated-and-closed-cell-therapy-processing-systems-market

The increasing clinical advancement of CAR-T therapies, stem cell therapies, and regenerative medicine programs is expected to support strong long-term market growth globally.

Key Highlights

• Largest Region: North America

• Fastest Growing Region: Asia-Pacific (CAGR 19.6%)

• Largest Segment by Product Type: Instruments

• Fastest Growing Segment by Product Type: Consumables (CAGR 19.1%)

• Largest Segment by Workflow: Cell Processing

• Fastest Growing Segment by Workflow: Cell Expansion (CAGR 18.9%)

• Largest Segment by End User: Biopharmaceutical and Biotechnology Companies

Market Dynamics

Drivers

The automated and closed cell therapy processing systems market is primarily driven by the growing commercialization of advanced cell therapies. As cell-based therapies progress from clinical trials toward commercial manufacturing, there is increasing demand for systems that can ensure process standardization, scalability, and reproducibility. Automated closed systems help minimize operator variability, reduce contamination risks, and improve manufacturing consistency, making them highly attractive for commercial-scale production.

Another major growth driver is the increasing number of clinical studies involving CAR-T cell therapies, stem cell therapies, and regenerative medicine applications. Research institutions and biotechnology companies are rapidly investing in advanced processing platforms to accelerate cell therapy development while improving manufacturing efficiency and regulatory compliance.

Restraints and Opportunities

A key restraint affecting market growth is the high capital investment associated with automated cell therapy manufacturing systems. Advanced automation platforms often require significant upfront costs, specialized infrastructure, and trained personnel, which may limit adoption among smaller research organizations and early-stage therapy developers.

However, the growing trend toward decentralized manufacturing and point-of-care cell therapy processing is creating substantial market opportunities. Technological innovation in modular closed-system platforms, integrated analytics, and digital workflow control is enabling greater flexibility and efficiency across cell therapy production. Expanding investments in personalized medicine and regenerative healthcare are expected to create strong long-term growth prospects through the forecast period.

Top Market Players

• Thermo Fisher Scientific Inc.

• Sartorius AG

• Miltenyi Biotec

• Lonza Group AG

• Fresenius Kabi AG

• Cytiva

• Terumo Corporation

• Danaher Corporation

• Cellares

• Fresenius Medical Care

• Bio-Techne Corporation

• Merck KGaA

• Wilson Wolf Manufacturing

• PBS Biotech Inc.

• Ori Biotech

Download the Free Sample Report - https://straitsresearch.com/report/automated-and-closed-cell-therapy-processing-systems-market/request-sample

Segmentation Analysis

By Product Type

• Instruments

• Consumables

• Software and Services

By Workflow

• Cell Isolation

• Cell Processing

• Cell Expansion

• Fill-Finish Operations

By Cell Type

• Stem Cells

• T Cells

• Others

By End User

• Biopharmaceutical and Biotechnology Companies

• Academic and Research Institutes

• Contract Development and Manufacturing Organizations (CDMOs)

• Hospitals and Clinics

By Region

• North America

• Europe

• Asia-Pacific (APAC)

• Middle East and Africa

• Latin America (LATAM)

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email:sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)